Is Atossa undervalued or overvalued?
As of 2025-03-16, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -1.07 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.72 USD, the upside of Atossa Therapeutics Inc is -248.62%. This means that Atossa is overvalued by 248.62%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.07 - -1.07 | -1.07 | -248.62% |
| P/E | (2.18) - (4.93) | (3.41) | -574.1% |
| DDM - Stable | (1.22) - (3.30) | (2.26) | -414.3% |
| DDM - Multi | (0.03) - (0.05) | (0.04) | -105.0% |
| Market Cap (mil) | 90.54 |
| Beta | 2.56 |
| Outstanding shares (mil) | 125.80 |
| Enterprise Value (mil) | 15.77 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.04% |
| Cost of Debt | 5.00% |
| WACC | 8.36% |